![A liquid biopsy test has detected changes in the BRCA1 or BRCA2 genes associated with ovarian and breast cancer that signal when the disease stops responding to treatment through platinum chemotherapy or poly ADP-ribose polymerase (PARP) inhibitors. [Source: © freshidea/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1322-218x150.jpeg "Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery")
![Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]](https://www.clinicalomics.com/wp-content/uploads/2019/01/169-218x150.jpeg "New Targets Identified For Lupus and Rheumatoid Arthritis")
New Targets Identified For Lupus and Rheumatoid Arthritis
Researchers part of a public-private partnership have identified new targets for the treatment of autoimmune diseases, including lupus and rheumatoid arthritis. That’s according to...
Illumina Prevails Against Ariosa in UK Patent Infringement Case
Illumina said it has won a decision in a U.K. patent court which sided with the company in ruling that one of its patents...
Are Dogs the New Early Cancer Detection Tool?
A dog’s sense of smell—more than 10,000 times more sensitive than that of our own—has been exploited by humans for centuries. Whether it is...
Invitae to Expand NIPS Services with Singular Bio Acquisition
Invitae said today it has agreed to acquire Singular Bio for $55 million, in a deal designed to bolster the buyer’s non-invasive prenatal screening...
Sensory Nanoparticles Could Enable Early Disease Detection
The discovery that blood biomolecules form distinctive corona profiles around nanoparticles could lead to early detection tests for cancer, and possibly other diseases as...
Gut Microbe Dampens Parkinson’s Treatment
For some time, gut microbes have been thought to metabolize and lessen the efficacy of levodopa, the primary drug treatment for Parkinson’s disease, but...
CRISPR Pioneers Partner with GSK to Launch Laboratory for Genomics Research
Gene-editing pioneers based at the University of California (UC) are partnering with GlaxoSmithKline (GSK) to establish a new laboratory that will explore how gene...
CRISPR-Cas9 Used to Create Primate Model of Autism
Researchers headed by teams at the Chinese Academy of Sciences, and Massachusetts Institute of Technology (MIT), have used CRISPR-Cas9 gene editing to engineer macaque...
Foundation Medicine CEO Cindy Perettie’s Top ASCO 2019 Takeaways
By Cindy Perettie, CEO, Foundation Medicine
The way ASCO started for me this year set the scene for what was an inspiring and fascinating weekend....
![NGS technology has enabled researchers to epidemiologically analyze DNA sequences by quickly deciphering mass quantities of genetic information in a short amount of time. [Heart illustration: iStock/SvetaP DNA double helix: iStock/Kagenmi]](https://www.clinicalomics.com/wp-content/uploads/2019/01/304-218x150.jpeg "Polygenic Risk Scores Predict Heart Disease Across Diverse Populations")
Polygenic Risk Scores Predict Heart Disease Across Diverse Populations
A new study confirms that the whole-genome approach for predicting heart disease in people who have never had a heart attack works and can...
